Patent AnalyticsExaminers
Menu

Application

19624020 · A CHIMERIC TRANSMEMBRANE RECEPTOR COMPRISING AT LEAST ONE T-CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS (TIGIT) POLYPEPTIDE REGION, T-CELLS EXPRESSING THE CHIMERIC HUMAN TIGIT SWITCH RECEPTOR, VECTORS WITH NUCLEIC ACIDS ENCODING FOR THE TIGIT RECEPTOR, KITS FOR PREPARING THE T-CELLS, AS WELL AS CORRESPONDING PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING A PATIENT HAVING A DISEASE AND FOR INCREASING CYTOTOXICITY OF A T-CELL IN ADOPTIVE CELL THERAPY

Filed 2026-09-14 · Pending The official file ↗ · Art unit · Clark+Elbing LLP

Office actions
0
first was
RCEs
0
no appeal
To first action
n/a
to disposition n/a
Statutes raised
·
0 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in